ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 323 filers reported holding ARGENX SE in Q1 2024. The put-call ratio across all filers is 0.99 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,721 | +336.8% | 4 | +300.0% | 0.00% | – |
| Q1 2024 | $394 | -48.2% | 1 | -50.0% | 0.00% | – |
| Q4 2023 | $761 | -97.3% | 2 | -96.5% | 0.00% | -100.0% |
| Q3 2023 | $28,023 | -2.7% | 57 | -25.0% | 0.01% | -25.0% |
| Q4 2022 | $28,791 | +15.2% | 76 | +7.0% | 0.01% | 0.0% |
| Q3 2022 | $25,000 | +127.3% | 71 | +144.8% | 0.01% | +166.7% |
| Q2 2022 | $11,000 | – | 29 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 285,198 | $106,259,071 | 29.06% |
| Avoro Capital Advisors LLC | 1,287,500 | $479,696,750 | 7.11% |
| Paradigm Biocapital Advisors LP | 181,172 | $67,501,064 | 6.40% |
| DCF Advisers, LLC | 25,700 | $9,575,310 | 5.86% |
| Artia Global Partners LP | 36,404 | $13,563,402 | 5.01% |
| Bellevue Group AG | 886,928 | $330,451,634 | 4.80% |
| Fairmount Funds Management LLC | 73,526 | $27,394,317 | 4.71% |
| Eagle Health Investments LP | 64,400 | $23,994,152 | 4.67% |
| Decheng Capital Management III (Cayman), LLC | 27,429 | $10,219,497 | 4.12% |
| RTW INVESTMENTS, LP | 482,195 | $179,656,213 | 3.74% |